Kacper Dywan

Kacper Dywan


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
KDKacper Dywan
Kacper Dywan
JKJoanna Kośka
Joanna Kośka
GŁGabriela Łocik
Gabriela Łocik
KMKatarzyna Moliszewska
Katarzyna Moliszewska
PKPaweł Kukiełka
Paweł Kukiełka
MBMichał Błaszkiewicz
Michał Błaszkiewicz
Introduction and Purpose: Plantar fasciitis (PF) is one of the most common causes of heel pain in adults, with a lifetime incidence of about 10%. Diagnosis is primarily clinical, based on patient history and physical examination. This study aims to present and compare treatment modalities for PF, including conservative and surgical options. Brief Description of the State of Knowledge: The plantar fascia is a dense connective tissue crucial for supporting the medial longitudinal arch and enabling efficient gait. PF most often affects individuals aged 45–65 and is frequently associated with elevated body mass index. A characteristic symptom is sharp heel pain upon rising in the morning, which improves with walking. Physical examination may include the Silfverskiöld test to assess gastrocnemius contracture. Imaging, such as radiography, ultrasonography, or MRI, can support diagnosis. Although PF often recurs, 85–90% of patients respond to conservative treatment. Historically, management relied on night splints, orthoses, NSAIDs, and corticosteroid injections. Current strategies emphasize stretching and strengthening exercises. Surgical treatment is reserved for refractory cases. Materials and methods: In this article, we utilized scientific literature describing various treatment approaches for patients with PF. Particular attention was given to diagnostic strategies and the appropriate use of imaging modalities. Treatment efficacies were compared, and potential adverse effects were also discussed. Conclusions: Multiple therapies for PF show similar efficacy. Conservative management should remain first-line, with surgery considered when nonoperative measures fail. Successful outcomes depend on individualized treatment, patient education, and adherence. Collaboration between orthopedic surgeons and physiotherapists plays a key role in optimizing care.

17 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MMMartyna Musiorska
Martyna Musiorska
JMJulia Mazurek
Julia Mazurek
JKJoanna Kośka
Joanna Kośka
GŁGabriela Łocik
Gabriela Łocik
KMKatarzyna Moliszewska
Katarzyna Moliszewska
MBMichał Błaszkiewicz
Michał Błaszkiewicz
Introduction and purpose: Rathke’s cleft cysts (RCCs) are benign, epithelium-lined lesions located in the sellar or suprasellar region, originating from remnants of Rathke’s pouch. While often asymptomatic and discovered incidentally, RCCs may lead to significant clinical symptoms due to compression of adjacent structures, including the pituitary gland and optic chiasm. The aim of this review is to provide a comprehensive overview of RCCs and emphasize the importance of accurate diagnosis and individualized management, especially in symptomatic cases. Material and methods: The review is based on scientific literature published between 2005 and 2025, retrieved from PubMed, Scopus and Google Scholar using the following keywords: “Rathke’s cleft cyst,”, “Rathke’s cyst diagnosis,” “Rathke’s cyst treatment,” “pituitary cyst surgery,” and “Rathke’s cyst recurrence”. Results: Analysis of the literature indicates that although most RCCs remain asymptomatic, a significant subset causes symptoms such as headaches, visual disturbances, and endocrine dysfunction. MRI remains the most effective diagnostic tool, while treatment typically involves transsphenoidal surgical drainage. Recurrence rates vary depending on the surgical technique and inflammatory changes within the cyst wall. Emerging approaches, such as steroid-eluting stents, show promise in reducing recurrence, though further research is needed. Conclusions: RCCs, though generally benign, may result in substantial morbidity in symptomatic patients. Accurate diagnosis, appropriate imaging, and tailored treatment are essential for optimal outcomes. Long-term follow-up is recommended due to the potential for recurrence, and novel interventions offer promising avenues for future management strategies.

26 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
ANAlicja Nowik
Alicja Nowik
JMJulia Mazurek
Julia Mazurek
JKJoanna Kośka
Joanna Kośka
JZJulia Załęcka
Julia Załęcka
KMKatarzyna Moliszewska
Katarzyna Moliszewska
MMMartyna Musiorska
Martyna Musiorska
Hereditary angioedema (HAE) is a condition characterized by recurrent edema caused by the dysfunction of bradykinin production. Advances in understanding the pathophysiology of this disease have changed the diagnostic approach, acute management and prophylaxis. Optimal treatment now combines early diagnosis, targeted therapy and patient education. This narrative review provides an overview of current evidence regarding the clinical presentation, treatment options and promising new therapies for HAE. A systematic search of the PubMed and Google Scholar databases was conducted using terms such as hereditary angioedema, therapeutics, C1 inhibitor deficiency, bradykinin and disease management. Additional relevant studies were identified by manually reviewing reference lists and citations. The basis for effective treatment is an accurate diagnosis based on clinical symptoms, family history, and laboratory test results. On-demand treatment, such as C1 esterase inhibitor (C1-INH), icatibant, and ecallantide provides rapid symptomatic control. Long-term prophylaxis with agents such as lanadelumab, berotralstat or plasma-derived C1 esterase inhibitor (pdC1-INH) significantly reduces the frequency of attacks and improves patients’ quality of life. New data confirm that modern biologic therapies can maintain disease control with a favorable safety profile. Current HAE treatment strategies emphasize personalized prophylaxis, adequate intervention in acute attacks and continuous patient education. Combining modern therapies with individual patient preferences improves daily functioning, mental well-being and overall prognosis.

14 July 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
PKPaweł Kukiełka
Paweł Kukiełka
KMKatarzyna Moliszewska
Katarzyna Moliszewska
JKJoanna Kośka
Joanna Kośka
KDKacper Dywan
Kacper Dywan
MBMichał Błaszkiewicz
Michał Błaszkiewicz
GŁGabriela Łocik
Gabriela Łocik
Background:Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), previously classified under non-alcoholic fatty liver disease (NAFLD), is an increasingly prevalent chronic liver disorder tightly linked to obesity, insulin resistance, and systemic metabolic dysfunction. It ranges from simple steatosis to nonalcoholic steatohepatitis (MASH), fibrosis, cirrhosis, and hepatocellular carcinoma. Objective:This review explores the current understanding of MASLD, emphasizing its multifactorial etiology, evolving pathophysiological mechanisms, clinical progression, and therapeutic strategies, including emerging pharmacological and lifestyle interventions. Methods:A structured review of peer-reviewed articles published between 2019 and 2025 was conducted using critical analysis of uploaded and curated literature focusing on MASLD’s pathogenesis, comorbidities, and treatment modalities. Findings:MASLD is driven by a combination of genetic, environmental, metabolic, and immunological factors. Recent insights into lipid dysregulation, gut-liver axis, immune modulation, and endocrine pathways have clarified mechanisms of disease progression. Weight loss remains a cornerstone of management, supported by emerging anti-obesity medications such as GLP-1 receptor agonists and dual agonists. Novel therapies targeting hepatic stellate cells, fibroinflammatory signaling, and microbiota-derived metabolites represent future avenues for precision-based treatment. Conclusion:Effective MASLD management necessitates an integrated approach combining lifestyle interventions, pharmacotherapy, and targeted therapeutics based on individual phenotypes. Continued research into molecular pathways and personalized strategies holds promise for disease reversal and improved patient outcomes.

5 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
JKJoanna Kośka
Joanna Kośka
GŁGabriela Łocik
Gabriela Łocik
KMKatarzyna Moliszewska
Katarzyna Moliszewska
PKPaweł Kukiełka
Paweł Kukiełka
JMJulia Mazurek
Julia Mazurek
MBMichał Błaszkiewicz
Michał Błaszkiewicz
Autism Spectrum Disorder (ASD) encompasses a range of neurodevelopmental traits that influence perception, communication, and social interaction, often accompanied by restricted behaviors and sensory sensitivities. This overview examines the relationship between ASD and gastrointestinal (GI) issues, which frequently co-occur and significantly impact quality of life for affected individuals. Gastrointestinal problems including constipation, diarrhea, and food sensitivities are commonly observed in children with ASD. These issues likely result from multiple interacting factors such as microbiota dysbiosis, immune dysregulation, intestinal hyperpermeability, and dietary patterns. Research has identified disrupted gut microbiome profiles in children with ASD, with increased presence of pathogenic bacteria and associated immune reactivity, including anti-gliadin antibodies. Diagnosing GI disorders in individuals with ASD remains challenging due to communication barriers and atypical sensory processing, with no standardized diagnostic methods currently available. Treatment approaches focus on microbiota restoration through dietary modifications, probiotics, and emerging therapies like Microbiota Transplant Therapy (MTT). Recent studies of MTT have demonstrated sustained improvements in both GI and behavioral symptoms, suggesting promising directions for future interventions that address both the gastrointestinal and behavioral aspects of ASD. Further research is needed to develop standardized diagnostic protocols and evidence-based treatments for this population.

12 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
JMJulia Mazurek
Julia Mazurek
MMMartyna Musiorska
Martyna Musiorska
JKJoanna Kośka
Joanna Kośka
GŁGabriela Łocik
Gabriela Łocik
KMKatarzyna Moliszewska
Katarzyna Moliszewska
MBMichał Błaszkiewicz
Michał Błaszkiewicz
Introduction and purpose: Propofol, widely used as an anesthetic and sedative, has seen a significant rise in its application, particularly in intensive care units, over the past decade. In recent years, numerous reports have highlighted the emergence of a propofol-related infusion syndrome (PRIS) in critically ill adults and, more commonly, children receiving continuous propofol infusion for sedation or anesthesia. Propofol-related infusion syndrome (PRI) is typically characterized by progressive metabolic acidosis, hemodynamic instability, and bradyarrhythmias that may remain unresponsive to aggressive pharmacological intervention. This paper provides a comprehensive review of the literature on PRIS, examining its clinical manifestations, proposed pathophysiological mechanisms, and potential strategies for managing the syndrome should it arise in clinical practice. The authors want to emphasize a remarkable role of careful evaluation of patients treating with propofol. Materials and methods: A thorough search of electronic databases, including PubMed and Google Scholar, was conducted using relevant keywords such as „Propofol-related infusion syndrome”, „Propofol”, „Propofol infusion”, „Propofol infusion syndrome”. All retrieved papers were evaluated for relevance based on their titles, abstracts, and full-text content. We used AI tools to grammatically correct text.